1. Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
- Author
-
Lambert, Jean-Philippe, Picaud, Sarah, Fujisawa, Takao, Hou, Huayun, Savitsky, Pavel, Uusküla-Reimand, Liis, Gupta, Gagan D, Abdouni, Hala, Lin, Zhen-Yuan, Tucholska, Monika, Knight, James D R, Gonzalez-Badillo, Beatriz, St-Denis, Nicole, Newman, Joseph A, Stucki, Manuel, Pelletier, Laurence, Bandeira, Nuno, Wilson, Michael D, Filippakopoulos, Panagis, Gingras, Anne-Claude, University of Zurich, and Filippakopoulos, Panagis
- Subjects
Models, Molecular ,Proteomics ,Protein Conformation ,JQ1 ,610 Medicine & health ,Antineoplastic Agents ,Cell Cycle Proteins ,Protein Serine-Threonine Kinases ,Article ,1307 Cell Biology ,Structure-Activity Relationship ,protein crystallography ,Neoplasms ,bromodomain ,1312 Molecular Biology ,Humans ,Protein Interaction Domains and Motifs ,Molecular Targeted Therapy ,Protein Interaction Maps ,rRNA ,nucleolus ,Cell Proliferation ,KacY ,rewiring ,Nuclear Proteins ,RNA-Binding Proteins ,Azepines ,Triazoles ,BET ,10174 Clinic for Gynecology ,Gene Expression Regulation, Neoplastic ,HEK293 Cells ,proteomic network ,AP-MS ,K562 Cells ,HeLa Cells ,Protein Binding ,Signal Transduction ,Transcription Factors - Abstract
Summary Targeting bromodomains (BRDs) of the bromo-and-extra-terminal (BET) family offers opportunities for therapeutic intervention in cancer and other diseases. Here, we profile the interactomes of BRD2, BRD3, BRD4, and BRDT following treatment with the pan-BET BRD inhibitor JQ1, revealing broad rewiring of the interaction landscape, with three distinct classes of behavior for the 603 unique interactors identified. A group of proteins associate in a JQ1-sensitive manner with BET BRDs through canonical and new binding modes, while two classes of extra-terminal (ET)-domain binding motifs mediate acetylation-independent interactions. Last, we identify an unexpected increase in several interactions following JQ1 treatment that define negative functions for BRD3 in the regulation of rRNA synthesis and potentially RNAPII-dependent gene expression that result in decreased cell proliferation. Together, our data highlight the contributions of BET protein modules to their interactomes allowing for a better understanding of pharmacological rewiring in response to JQ1., Graphical Abstract, Highlights • Treatment with JQ1 induces an extensive BET proteins interactome rewiring • Structural and biophysical studies expand the target space for BET bromodomains • Two distinct short linear motifs mediate BET ET domain interactions • BRD3 negatively regulates proliferation through Pol I and II mechanisms, Lambert, Picaud, et al. report that pharmacological bromodomain inhibition rewires the interactome of the Bromo and Extra-Terminal (BET) proteins, resulting in loss (e.g., histones), maintenance, or gain of interactions. They reveal new binding modalities and an unsuspected negative role for BRD3 in proliferation.
- Published
- 2019